BB Lohray, VB Lohray, B Pandey… - US Patent 7,872,019, 2011 - Google Patents Illlllllllllllllllllllllllllllllllll US007872019B2 United States Patent Lohray et al. (io) Patent No.: (45) Date of Patent: US 7,872,019 B2 Jan. 18, 2011 (56) POLYMORPHS AND AMORPHOUS FORM OF (S)-(+)-CLOPIDOGREL BISULFATE Inventors: Braj B. Lohray, Gujarat (IN); Vidya B. ... Related articles - All 3 versions
AK Arora, T Sato… - Journal of Physics: Condensed …, 2011 - iopscience.iop.org ... pressure. The high-density amorphousform appears to have higher oxygen coordination as compared to the low-density amorphousform. ... These qualitative differences in S(Q) suggest structural changes in the amorphousform. Qualitative ... Related articles - All 6 versions
[PDF] from electrostatics.orgM Nyström, M Murtomaa… - Journal of Electrostatics, 2011 - Elsevier ... Available online 8 May 2011. Abstract. It is estimated that more than 95% of new drug candidates suffer from limited bioavailability [1]. Particle size reduction and formation of amorphousform are commonly used techniques in modifying bioavailability of such drugs. ... Related articles - All 2 versions
[PDF] from columbia.eduT Dykhne, R Taylor, A Florence… - Pharmaceutical research, 2011 - Springer ... TS-PDF data were collected from melt-quenched (amor- phous) samples of carbamazepine (CBZ), an anti-epileptic drug, and indomethacin (IND), a non-steroidal anti- Use of PDF in AmorphousForm Fingerprinting Page 4. ... Use of PDF in AmorphousForm Fingerprinting Page ... Cited by 2 - Related articles - All 4 versions
[PDF] from pharmacie-globale.infoKR Bobe, CR Subrahmanya… - International …, 2011 - pharmacie-globale.info ... Solid dispersion prepared with PEG 4000 shows the presence of amorphousform confirmed by the characterization study .The study also shows the that dissolution rate of Atorvastatin can be enhanced to considerable extent by solid dispersion technique with PEG. ... Cited by 1 - Related articles - View as HTML - All 2 versions